Literature DB >> 35586559

Case Report and Literature Review of Impetigo-Like Tinea Faciei.

Fangfang Zhang1,2, Yahui Feng1, Sisi Wang3, Dongmei Li4, Dongmei Shi3,5.   

Abstract

Impetigo, commonly caused by bacteria, is characterized by lesions of pustules, bullae or golden yellow crusts; it is seldom caused by fungi. Here, we report one case of a 17-year-old female patient with a 1-month history of erythematous pustules on her left cheek. She was clinically diagnosed with "impetigo", but did not respond to 1 week of treatment with topical mupirocin cream (antibacterial agent). We then saw that a fungal colony grew on the culture, which was identified as T. mentagrophytes based on the morphological and molecular characteristics. The patient was then diagnosed with tinea faciei and was topically treated with 0.2% ketoconazole cream twice per day for 7 days. Through a literature review, we found another 18 cases of impetigo-like tinea faciei with similar clinical manifestations and pathogenic characteristics. Among these, the most common causative agent was T. mentagrophytes complex, which frequently occurs in children and adolescents and exhibits no gender preferences. Systemic and topical antifungals such as terbinafine or itraconazole are effective for impetigo-like tinea faciei caused by T. mentagrophytes complex. However, prolonged course of impetigo in more than 50% cases highlights the importance of mycological examination when dealing with apparent antibiotic-resistant impetigo cases in clinical settings.
© 2022 Zhang et al.

Entities:  

Keywords:  Trichophyton mentagrophytes; impetigo; tinea faciei

Year:  2022        PMID: 35586559      PMCID: PMC9109911          DOI: 10.2147/IDR.S359500

Source DB:  PubMed          Journal:  Infect Drug Resist        ISSN: 1178-6973            Impact factor:   4.177


Introduction

Tinea faciei is a relatively uncommon superficial dermatophyte infection that occurs on the smooth regions of the face and as reported, affects both sexes and all age groups.1,2 But it has two peaks of incidence: the first peak occurs in children at 2 to 14 years of age with a predominance among males, often after contact with domestic animals, with rare cases described in babies younger than 12 months.3,4 The second peak is seen in adults aged 40 and older, with a prevalence among women resulting from occupational exposure or leisure activities.5 Indeed, the female predominance may not even be accurate, since dermatophyte infections on the bearded areas of males are often diagnosed as tinea barbae. With regard to aetiology, the causative agents of the infection are mainly M. canis, T. mentagrophytes and T. rubrum, respectively.6,7 At present, methods for identification of dermatophytes comprise both molecular methods and phenotypic approaches. Although microscopic examination and culture (of dermatophytes) can be used as a diagnostic tool in the hands of an experienced mycologist, species identification from fungal culture still take a relatively long time for this group of fungi. Molecular techniques such as real-time PCR and gene sequencing have been greatly appreciated for the accurate diagnosis of fungal infection. They still serve as the gold standard for differential diagnosis of fungal infections caused by morphologically similar species, but molecular methods are costly.8 In terms of clinical manifestations, typical lesions of tinea faciei are characterized by one or more erythematous macules and circular erythematous-scaling patches with central clearing. However, the occasional absence of these lesions frequently leads to misdiagnosis as eczema, contact dermatitis, seborrheic dermatitis, folliculitis, cutaneous lupus erythematosus, rosacea, psoriasis, purpura, or pemphigus.9–17 It has even been reported that up to 70% of patients with tinea faciei were initially misdiagnosed.1 As a result of misdiagnosis, lesions are often treated with topical steroids or calcineurin inhibitors, which in turn exacerbate the inflammatory symptoms, leading to more severe erythema and scaling, newly scattered pustules or papules. These inflammatory symptoms deviate from the characteristic features of dermatophytosis and often lead to delays in diagnosis and appropriate antifungal therapy.18–20 Tinea faciei rarely mimic impetigo in clinical manifestations.9,21,22 Impetigo is a contagious, superficial bacterial infection of the skin commonly caused by Staphylococcus aureus and most frequently occurs in children 2–5 years of age.23–25 It is characterized by discrete, thin-walled vesicles that rapidly become pustular and then rupture.23,26 Here, we report a case of tinea faciei caused by T. mentagrophytes which mimics bacterial impetigo. We include 18 published tinea faciei cases whose lesions mimic bacterial impetigo (Table 1) and their clinical and mycological features are reviewed.4,13,27–42
Table 1

Cases of Impetigo-Like Tinea Faciei

RefsAgeSexHistoryCausative AgentSpeciesPossible SourceTreatmentCountry
420DF4DT. mentagrophytesZ/T: CMZIndia
133YF25DA. gertleri (formerly A. vanbreuseghemmii); S. aureusZCombO: ITC; T: NTF; KCZ;China
2736YF1MT. benhamiae (formerly A. benhamiae)ZRabbits; Guinea pigsO: TRB; T: KMZJapan
2814MM2MN. gypsea (formerly M. gypseum)ZDogT: TRBBrazil
296YM2MT. verrucosumZFarmO: ITC/
305YM20DN. gypsea (formerly M. gypseum)ZTrauma; SoilT: KCZChina
315YM7DT. mentagrophytesZAnimals/China
329YM14DT. erinacei (formerly T. mentagrophytes var. erinacei)ZHedgehogT: TRBSpain
339YF7MT. mentagrophytesZCatO: ITC; T: NTFChina
3411YM1MM. canisZCatT: KCZTunisia
3518YF5WT. interdigitaleZRabbitO: TRB; T: NTF-KCZChina
3621YF2WT. erinacei (formerly T. mentagrophytes var. erinacei)ZHedgehogsO: TRB; T: TRBChile
3710YF2WT. erinacei (formerly T. mentagrophytes var. erinacei)ZHedgehogO: ITCKorea
384YF4MM. canisZ/O: TRBUK
3931YF4MT. rubrumATraumaO: TRBUruguay
409YM/T. benhamiae (formerly A. benhamiae)ZGuinea pigsO: TRB; T: TRBSpain
4153YM/T. mentagrophytesZ/O: ITC; T: ITCSpain
4221dM7dT. tonsuransA/O: GRFChicago
Ours17YF1MT. mentagrophytesZCatT: KCZChina

Abbreviations: /, Undetected; Y, Year; M, Month (in age); D, Day, F, Female; M, Male (in sex); ITC, Itraconazole; TRB, Terbinafine; NTF, Naftifine; KCZ, Ketoconazole; KMZ, Clotrimazole; GRF, Griseofulvin; Refs, References; A, Anthropophilic; Z, Zoophilic; O, Oral; T, Topical.

Cases of Impetigo-Like Tinea Faciei Abbreviations: /, Undetected; Y, Year; M, Month (in age); D, Day, F, Female; M, Male (in sex); ITC, Itraconazole; TRB, Terbinafine; NTF, Naftifine; KCZ, Ketoconazole; KMZ, Clotrimazole; GRF, Griseofulvin; Refs, References; A, Anthropophilic; Z, Zoophilic; O, Oral; T, Topical.

Case Presentation

A 17-year-old female presented with a 1-month history of progressive erythematous and pustules involving the left cheek on her first visit to our hospital on Jan. 5, 2021. One month prior, initial lesions appeared on her left cheek as tiny erythematous macules and pustules. The patient complained of itching. Gradually, most of the erythematous macules came to be covered with loosely stratified golden-yellow crusts; the patient was clinically diagnosed with “impetigo”. The patient was topically treated with 2% mupirocin cream for 7 days, but the lesions gradually enlarged and spread on both cheeks and the chin. The patient had a history of 4 weeks of close contact with a cat, but no minor trauma or other medical events. Physical examination showed several erythematous macules ranging from 0.5 cm to 1 cm in diameter on both cheeks and chin. Most of erythematous lesions were eventually covered with golden-yellow scales or crusts which were readily removed as shown in Figure 1A–C. Regional lymph nodes were not palpable.
Figure 1

Images of the lesions before treatment (A–C). Image of the lesions on her right cheek (A). Image of the lesions on her chin (B). Image of the lesions on her left cheek (C).

Images of the lesions before treatment (A–C). Image of the lesions on her right cheek (A). Image of the lesions on her chin (B). Image of the lesions on her left cheek (C). The scales taken from the lesions were stained with calcofluor white and septate hyphae were observed under fluorescent microscopy. Meanwhile, the scales were inoculated and cultured at 28°C on Sabouraud-glucose Agar with Chloramphenicol (SDA) (Hope Bio-Technology Co., Ltd., Qingdao, Shandong, China) for fungal growth and Columbia Blood Agar (CBA) (Hope Bio-Technology Co., Ltd., Qingdao, Shandong, China) for bacterial growth, respectively. A white fungal colony was evident after 1 week, which was peripherally radiating but centrally raised with powdery margins (Figure 2A) and a yellow to brown color on the reverse side of the plate (Figure 2B). Under microscopy, a grape-like arrangement of the microconidia was observed laterally and terminally distributed along filamentous and spiral hyphae (Figure 2C and D). Conversely, there was no growth of bacteria on the CBA.
Figure 2

The strain was cultured on SDA at 28 °C for 1 week. The images of colony showing white colonies peripherally radiating, centrally raised, and powdery margins (A), and the reverse side showed yellow to brown colonies (B). The strain staining with lactophenol cotton blue was observed under light microscope showing filamentous and spiral hyphae, microconidia and macroconidia (original magnification × 200) (C), and a grape-like arrangement of microconidia laterally and terminally inserting at the hyphae (original magnification × 400) (D).

The strain was cultured on SDA at 28 °C for 1 week. The images of colony showing white colonies peripherally radiating, centrally raised, and powdery margins (A), and the reverse side showed yellow to brown colonies (B). The strain staining with lactophenol cotton blue was observed under light microscope showing filamentous and spiral hyphae, microconidia and macroconidia (original magnification × 200) (C), and a grape-like arrangement of microconidia laterally and terminally inserting at the hyphae (original magnification × 400) (D). Subsequently, the isolated fungal species were identified by sequencing the internal transcribed spacer (ITS) and β-tubulin gene using the fungal primers as follows: ITS1 (5′-TCCGTAGGTGAACCTGCGG-3′), ITS4 (5′-TCCTCCGCTTATTGATATGC-3), β-tubulin 2a (5′-AATTGGTGCCGCTTTCTGG-3′) and β-tubulin 2b (5′-AGTTGTCGGGACGGAATAG-3′).43 The sequencing data were aligned with reference sequences in GenBank (). Our target sequence obtained a 99% coverage and 99.27% homology with T. mentagrophytes No. WCH-AV003, and a 99% coverage and 99.27% homology with T. mentagrophytes No. DSM-108626, which can be accessed in GenBank with registration number MZ712214.1. The strain (No. CCJNMM-1678) was stored in the laboratory of medical mycology, Jining No. 1 People’s Hospital. A phylogenetic tree in Figure 3 was constructed based on the results of BLAST searches through GenBank with ITS and β-tubulin sequences using the maximum-likelihood method in MEGA 7.0.44 Phylogenetic evaluation used the neighbor-joining method with 1000 bootstrap simulations; bootstrap values greater than 70% were regarded as significant. The type strain of Microsporum gypseum (actually Nannizzia gypsea) CBS 146.66 was used as an outgroup. The antifungal sensitivity test was followed using the broth dilution method of the Laboratory Standards Institute (CLSI) M38-A3 protocol with antifungal agents, terbinafine, amphotericin B, ketoconazole, itraconazole, posaconazole, voriconazole, or micafungin.45 The minimum inhibitory concentrations (MIC) for terbinafine, amphotericin B, ketoconazole, itraconazole, posaconazole, voriconazole and micafungin were 0.015, 0.125, 0.03, ≤0.03, ≤0.03, ≤0.03 and 8 μg/mL, respectively.
Figure 3

Maximum likelihood phylogenetic tree created from ITS and β-Tubulin sequences of 31 Trichophyton species including CCJNMM-1678 and 30 representative type strains sequences with bootstrap above 70% are shown. The phylogenetic tree was rooted with Microsporum gypseum (actually Nannizzia gypsea) CBS 146.66.

Maximum likelihood phylogenetic tree created from ITS and β-Tubulin sequences of 31 Trichophyton species including CCJNMM-1678 and 30 representative type strains sequences with bootstrap above 70% are shown. The phylogenetic tree was rooted with Microsporum gypseum (actually Nannizzia gypsea) CBS 146.66. Our patient was then diagnosed with impetigo-like tinea faciei caused by T. mentagrophytes. The patient was given 0.2% ketoconazole cream twice a day. The lesions completely ceased to be visible after 1 week (Figure 4A–C). Direct and fluorescence mycological examination in a 2-week follow-up showed negative for fungal growth.
Figure 4

The lesions completely disappeared after one week of treatment with 0.2% ketoconazole cream (twice daily) (A–C). Images of the patient’s right cheek (A), chin (B) and left cheek (C) after the treatment.

The lesions completely disappeared after one week of treatment with 0.2% ketoconazole cream (twice daily) (A–C). Images of the patient’s right cheek (A), chin (B) and left cheek (C) after the treatment.

Discussion and Conclusion

Tinea faciei is a relatively uncommon superficial dermatophyte infection accounting for 3% to 4% of all cases of tinea corporis.1 The infection, when limited to the glabrous skin of the face, can present with many atypical lesions, including the impetigo-like symptoms we report here.9,21,46,47 Because impetigo-like tinea faciei is rare and easily overlooked in clinical settings, we believe the misdiagnosis rate is high. Indeed, in our literary collection of 18 impetigo-like tinea faciei cases, 11 of the 18 cases were misdiagnosed before pathogen determination. As a result of misdiagnosis, these cases were typically treated with topical steroids or calcineurin inhibitors for their anti-inflammatory effects, which in turn accelerated dermatophyte growth and made the diagnosis more difficult to defend, even without the resulting delays in proper antifungal therapy.29,39,42 We include our case with those 18 cases to summarize the clinical features and fungal distribution of impetigo-like tinea faciei with the aim of helping diagnosis in future. Epidemiologically, tinea faciei is widespread globally but prefers humid tropical climates. Among the 19 cases, 5 were reported in China, 3 in Spain and the remaining 11 appeared to be scattered throughout the rest of the world. Furthermore, the sexes were represented roughly equally: 10 cases of females (53%) and 9 cases of males (47%). Impetigo-like tinea faciei affects all age groups, which differs from “true” impetigo commonly caused by bacteria in children from 2 to 5 years of age.23 Impetigo-like tinea faciei in children and adolescents accounted for 79% of the 19 cases, of which 7 occurred before the age of 5, 8 occurred at ages 5–18, and 4 cases appeared in adults over 18. We have no complete explanation for the predilection of impetigo-like tinea faciei for younger patients, but we note that 17 patients reported a history of close contact with domestic animals, and the remaining two cases were unable to categorically deny such contact. This evidence is bolstered by the fact that the 17 cases were infected by zoophilic species, specifically 12 cases of T. mentagrophytes complex (63.2%), 1 case of T. verrucosum, 2 cases of Nannizzia gypsea, and 2 cases of M. canis-in contrast to the 2 cases of anthropophilic species (T. rubrum and T. tonsurans). As others have observed, infections caused by zoophilic species tend to be self-healing, and the resultant inflammation is more severe when accompanied by papules, vesicles and pustules.48,49 The dominant T. mentagrophytes strain in these patients is a well-known zoophilic fungus that generally only infests the stratum corneum of the epidermis and induces a higher inflammatory reaction than anthropophilic fungi,50 which could easily mimic impetigo in these patients.51,52 We therefore emphasize the importance of obtaining a detailed history of any animal contact for impetigo patients in particular with severe inflammatory lesions. To date, the increase in the keeping of exotic animals as pets has resulted in the emergence of several zoonotic diseases that could potentially be transmitted to humans as well. Although the person-to-person transmission route is still more common for dermatophytosis, the roles of environmental reservoirs such as clothes, bed linen, mattresses and infected pets should not be ignored in order to control fungal infection.53 With regard to the identification of a species within a complex, phylogenetic tree based on the sequences of the ITS regions could be useful to describe the evolutionary relationship among these species. However, even though the use of more genetic markers beyond ITS regions has been remarkably successful in delineating most species, the discrimination of species in Trichophyton complex clade remains difficult.54 T. mentagrophytes complex comprises five species as follows: T. mentagrophytes, T. interdigitale, T. erinacei, T. quinckeanum, and T. benhamie, as well as nine other morphologically similar genotypes of T. mentagrophytes/T. interdigitale.55 In addition to the genetic method, the matrix-assisted laser desorption/ionization-time-of-flight (MALDI-TOF) mass spectrometry (MS)-based strategy (an emerging microbial protein profile identification system) has also been explored for facilitating identification of clinical dermatophyte isolates.19 One study even used MALDI-TOF MS strategy combined with the traditional methods to identify T. benhamiae.40 However, lack of complete databases of filamentous fungal species and standardized procedures limit the practicality of MALDI-TOF MS in dermatophyte detection. Clinically, the lesions of impetigo-like tinea faciei are easily misdiagnosed as bacterial impetigo. The delayed treatment then prolongs the course of the disease. Lesions often persist more than one month and even up to 2 years before the diagnosis are correct. The durations of cases listed in Table 1 range from 4 days to 7 months with 10 cases lasting more than 1 month. This prolonged course again highlights the importance of mycological examination when dealing with apparent antibiotic-resistant impetigo cases.56 Treatment of tinea faciei is the same as for other superficial fungal infections. Most tinea faciei cases are curable with topical antifungal treatments.9,57 Systemic antifungal treatment is recommended for severe or prolonged cases.57 Since zoophilic fungi could induce a high inflammatory response, an anti-inflammatory steroid can be given simultaneously, but never without the antifungals.58 Dermatophytes vary in their susceptibility to the available antifungal agents, but most dermatophytes are susceptible to antifungals although drug resistant strains have been reported recently.59,60 Among these impetigo-like tinea faciei cases, 7 of 19 were cured with topical antifungal treatments alone and 12 cases were cured with oral antifungal treatments alone or in combination with topical drugs. The oral antifungals used in those 12 cured patients were terbinafine or itraconazole (11 patients) or griseofulvin (1 case). In other studies, terbinafine has been shown to be an effective antifungal against dermatophyte isolates.61 However, dermatophytes resistant to terbinafine have emerged recently.7,20,59,60,62 Therefore, it is vitally important to perform in vitro antifungal susceptibility tests (AFST) to guide therapeutic measures.20 In summary, impetigo-like tinea faciei is a superficial dermatophyte infection of the skin commonly caused by T. mentagrophytes complex; it most frequently occurs in children and adolescents and seldom occurs in adults. One limitation of this study is the small number of representative cases which somewhat hamper our conclusion. When children or adolescents with impetigo-like lesions present with severe inflammation but do not respond to antibiotics, mycological examination should be done in order to facilitate a correct diagnosis and provide guidance on treatment.
  59 in total

1.  Tinea faciei due to microsporum canis in children: a survey of 46 cases in the District of Cagliari (Italy).

Authors:  Laura Atzori; Natalia Aste; Nicola Aste; Monica Pau
Journal:  Pediatr Dermatol       Date:  2011-10-20       Impact factor: 1.588

2.  Tinea faciei due to Microsporum canis abscess formation.

Authors:  G Patel; C Mills
Journal:  Clin Exp Dermatol       Date:  2000-11       Impact factor: 3.470

3.  Tinea faciei simulating other dermatoses.

Authors:  L Shapiro; H J Cohen
Journal:  JAMA       Date:  1971-03-29       Impact factor: 56.272

4.  The first case of tinea faciei caused by Trichophyton mentagrophytes var. erinacei isolated in Chile.

Authors:  Marcela Concha; Claudia Nicklas; Elvira Balcells; Ana María Guzmán; Helena Poggi; Eugenia León; Felix Fich
Journal:  Int J Dermatol       Date:  2012-03       Impact factor: 2.736

5.  Terbinafine Resistance of Trichophyton Clinical Isolates Caused by Specific Point Mutations in the Squalene Epoxidase Gene.

Authors:  Tsuyoshi Yamada; Mari Maeda; Mohamed Mahdi Alshahni; Reiko Tanaka; Takashi Yaguchi; Olympia Bontems; Karine Salamin; Marina Fratti; Michel Monod
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

6.  Epidemiological survey of 42 403 dermatophytosis cases examined at Nagasaki University Hospital from 1966 to 2015.

Authors:  Motoi Takenaka; Hideyuki Murota; Katsutaro Nishimoto
Journal:  J Dermatol       Date:  2020-04-15       Impact factor: 4.005

7.  Investigation of in vitro antifungal susceptibility testing and genetic diversity of clinical isolates of Trichophyton benhamiae and Trichophyton eriotrephon in Iran.

Authors:  Saham Ansari; Bahram Ahmadi; Mohammad T Hedayati; Sadegh Nouripour-Sisakht; Mojtaba Taghizadeh-Armaki; Mobina Fathi; Niloofar Deravi; Gholam-Reza Shokoohi; Ali Rezaei-Matehkolaei
Journal:  Mycoses       Date:  2020-11-15       Impact factor: 4.377

8.  Tinea faciei on the right eyebrow caused by Trichophyton interdigitale.

Authors:  Kai Wen Zhuang; Ya Ling Dai; Yu Ping Ran; Jebina Lama; Yi Ming Fan
Journal:  An Bras Dermatol       Date:  2016 Nov-Dec       Impact factor: 1.896

9.  Low in vitro activity of sertaconazole against clinical isolates of dermatophyte.

Authors:  Mahsa Behnam; Hossein Zarrinfar; Mohammad Javad Najafzadeh; Ali Naseri; Lida Jarahi; Monika Novak Babič
Journal:  Curr Med Mycol       Date:  2020
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.